{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65cf3713d18c7b0016eabe7b/65cf37188cc7730016aa4751?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"RPS Pharma Scene #26","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/65cf3713d18c7b0016eabe7b/65cf37188cc7730016aa4751.jpg?height=200","description":"<p>In this 26th episode of the Royal Pharmaceutical Society Pharma Scene podcast, regular host Ciara Duffy is joined by Rebecca Stanbrook, Executive Director, Development and Regulatory Policy at Novartis. </p> <p>She talks to Ciara about clinical trials and regulatory affairs, and they discuss some of the entry roads into the industry.</p> <p>Rebecca sits on the RPS' <a href= \"https://www.rpharms.com/about-us/who-we-are/expert-advisors/industrial-pharmacy-advisory-group\" target=\"_blank\" rel=\"noopener\">Industrial Pharmacy Advisory Group</a>, and has had a fascinating career in pharmacy. If you're thinking about a career in clinical trials and regulation, then you'll find this discussion <em>very</em> interesting!</p>","author_name":"Royal Pharmaceutical Society"}